{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:22:13Z","timestamp":1792365733686,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.neuropharm.2006.09.013","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T12:29:44Z","timestamp":1162988984000},"page":"796-801","source":"Crossref","is-referenced-by-count":21,"title":["The novel anxiolytic ELB139 displays selectivity to recombinant GABAA receptors different from diazepam"],"prefix":"10.1016","volume":"52","author":[{"given":"Holger","family":"Rabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kronbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Rundfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"L\u00fcddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.09.013_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1568007033482841","article-title":"Anxioselective compounds acting at the GABAA receptor benzodiazepine binding site","volume":"2","author":"Atack","year":"2003","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjp.0706056","article-title":"Anxiogenic properties of an inverse agonist selective for \u03b13 subunit-containing GABAA receptors","volume":"144","author":"Atack","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-tiazol-3-ylmethoxy)-3-(2-fluorophenyl)-1, 2,4,-triazolo[4,3-b]pyridazine], an agonist selective for \u03b12- and \u03b13-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib4","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the \u03b15 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib5","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal \u03b15 GABAA receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib6","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of {alpha}3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29437-4","article-title":"SL651498: an Anxioselective compound with functional selectivity for \u03b12- and \u03b13-containing \u03b3-aminobutyric acidA (GABAA) receptors","volume":"298","author":"Griebel","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib8","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm0509400","article-title":"Synthesis, pharmacology, and structure\u2013activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors","volume":"49","author":"Grunwald","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib9","first-page":"970","article-title":"Cloning of cDNA sequences encoding human \u03b12 and \u03b13 \u03b3-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant \u03b11-, \u03b12-, \u03b13-, and \u03b15-containing human \u03b3-aminobutyric acidA receptors","volume":"43","author":"Hadingham","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib10","first-page":"1211","article-title":"Role of the \u03b2 subunit in determining the pharmacology of human \u03b3-aminobutyric acid type A receptors","volume":"44","author":"Hadingham","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02741459","article-title":"The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes","volume":"18","author":"Hevers","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib13","first-page":"87","article-title":"Regional \u03b3-aminobutyric acid sensitivity of t-butylbicyclophosphoro[35S]thionate binding depends on \u03b3-aminobutyric acidA receptor \u03b1 subunit","volume":"44","author":"Korpi","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/07853899708999348","article-title":"GABAA-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands","volume":"29","author":"Korpi","year":"1997","journal-title":"Ann. Med."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1360-0443.1994.tb03737.x","article-title":"Biological processes in benzodiazepine dependence","volume":"89","author":"Lader","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib16","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.105.084681","article-title":"Characterisation in rats of the anxiolytic potential of ELB139, a new agonist at the benzodiazepine binding site of the GABAA receptor","author":"Langen","year":"2005","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib17","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.0502579102","article-title":"Selective anxiolysis produced by ocinaplon, a GABAA receptor modulator","volume":"102","author":"Lippa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib19","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1523\/JNEUROSCI.15-10-06957.1995","article-title":"GABA antagonists differentiate between recombinant GABAA\/benzodiazepine receptor subtypes","volume":"15","author":"L\u00fcddens","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib20","series-title":"Methods in Molecular Biology","first-page":"55","article-title":"Methods for transient expression of hetero-oligomeric ligand-gated ion channels","author":"L\u00fcddens","year":"1997"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0028-3908(94)00158-O","article-title":"GABAA\/benzodiazepine receptor heterogeneity: neurophysiological implications","volume":"34","author":"L\u00fcddens","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/346648a0","article-title":"Cerebellar GABAA receptor selective for a behavioural alcohol antagonist","volume":"346","author":"L\u00fcddens","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0091-3057(97)00539-X","article-title":"Benzodiazepine dependence: from neural circuits to gene expression","volume":"59","author":"Pratt","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1471-4159.1990.tb01237.x","article-title":"\u03b3-Aminobutyric acidA receptor \u03b15-subunit creates novel type II benzodiazepine receptor pharmacology","volume":"54","author":"Pritchett","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","article-title":"Type I and type II GABAA-benzodiazepine receptors produced in transfected cells","volume":"245","author":"Pritchett","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","article-title":"Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology","volume":"338","author":"Pritchett","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib28","series-title":"GABAA Receptor Subtype Selectivity of the Benzodiazepine Receptor Ligand ELB139","author":"Rabe","year":"2005"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific \u03b3-aminobutyric acidA receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1520-6769(199611)19:3<169::AID-NRC177>3.0.CO;2-F","article-title":"Failure of long-term administration of zopiclone and zolpidem to induce tolerance in mice","volume":"19","author":"Serra","year":"1996","journal-title":"Neurosci. Res. Commun."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)01118-8","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0896-6273(90)90224-4","article-title":"The effect of subunit composition of rat brain GABAA receptors on channel function","volume":"5","author":"Sigel","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2006.09.013_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution\u00a0of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon","volume":"12","author":"Wisden","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.09.013_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(91)81076-K","article-title":"Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor \u03b14 subunit","volume":"289","author":"Wisden","year":"1991","journal-title":"FEBS Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080600339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839080600339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T22:27:49Z","timestamp":1736634469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839080600339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S002839080600339X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.09.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}